FIELD: pharmaceutics.
SUBSTANCE: invention relates to a compound of the following formula (I): [Chem. 1]
,
wherein A is phenyl or 6-membered heteroaryl containing 1 to 2 heteroatoms of N; B is selected from the group consisting of -C1-6 alkylene-NR2-, -NR2- and -(C=O)-; C is selected from the group consisting of -(C=O)- and -NR2-; R1 is independently selected from the group consisting of: (2) -On-C1-6 alkyl wherein alkyl is unsubstituted or substituted by one or more substituents independently selected from R11, (3) -On-C3-7 cycloalkyl, where cycloalkyl is unsubstituted, (4) -On-phenyl, wherein phenyl is unsubstituted or is substituted by one or more substituents independently selected from R11, (6) -S-phenyl, wherein phenyl is unsubstituted or is substituted by one or more substituents independently selected from R11; (7) -NH-C1-6 alkyl wherein alkyl is unsubstituted or substituted by one or more substituents independently selected from R11, and (9) -On- (5-membered heteroaryl containing 1-2 heteroatoms selected from N), wherein heteroaryl is unsubstituted or substituted by one or more substituents independently selected from R11; R2 are independently selected from the group consisting of: (1) hydrogen, (2) halogen selected from chlorine, bromine and fluorine, (4) -On-C1-6 alkyl, (8) -On-(6-membered heterocyclyl containing 1 N atom), wherein heterocyclyl is unsubstituted or is substituted by one or more substituents independently selected from R7, (9) -(C=O)-NR8R9 and (10) -NR8R9; R3 and R4 are independently hydrogen or C1-6 alkyl; R5 are independently selected from the group consisting of: (1) hydrogen and (3) -On-C1-6 alkyl; R6 is independently hydrogen, C1-6 alkyl, C1-6 alkoxy, C3-7 cycloalkyl, -NR8R9, 4-6 membered heterocyclyl containing 1-2 heteroatoms selected from N and O, phenyl, 5-6 membered heteroaryl containing 1-2 heteroatoms selected from N, O and S, phenyl-C1-6 alkyl, (5-membered heteroaryl containing 2-3 heteroatoms selected from N) -C1-6alkyl or (6-membered heterocyclyl containing 1-2 heteroatoms selected from N and O) -C1-6 alkyl, R6 can form a 5-6-membered ring with R2. Values of other radicals are given in the patent claim. Invention also relates to compound of formula (II), compound of formula (III), pharmaceutical composition, condition or disorder treatment method, in which TTX-S channel blockers are involved, use of the compound, method for preparing a pharmaceutical composition, use of the composition.
EFFECT: new compounds of formula (I) have been obtained which have blocking activity with respect to potential-dependent sodium channels as TTX-S channels and which can be used in the treatment or prevention of disorders and diseases in which potential-dependent sodium channels are involved.
15 cl, 4 tbl, 520 ex
Title | Year | Author | Number |
---|---|---|---|
PYRAZOLOPYRIDINE DERIVATIVES AS TTX-S BLOCKERS | 2013 |
|
RU2652117C2 |
ARYLAMIDE DERIVATIVES AS TTX-S BLOCKERS | 2011 |
|
RU2535671C1 |
NEW COMPOUNDS AND COMPOSITIONS FOR NAMPT INHIBITION | 2011 |
|
RU2617988C2 |
SPIROCYCLIC PYRROLOPYRAZINE(PIPERIDINE)AMIDES AS IONIC CHANNELS MODULATORS | 2012 |
|
RU2634900C2 |
AMIDE DERIVATIVES AS TTX-S BLOCKERS | 2013 |
|
RU2632899C2 |
BICYCLIC LACTAMS AND METHODS FOR USE THEREOF | 2016 |
|
RU2716136C2 |
AMIDES OF CONDENSED PIPERIDINE AS MODULATORS OF ION CHANNELS | 2014 |
|
RU2741810C2 |
BROMODOMAIN INHIBITORS | 2017 |
|
RU2741808C2 |
SUBSTITUTED TRICYCLIC COMPOUNDS AND METHOD OF APPLICATION | 2016 |
|
RU2744766C2 |
NOVEL PHENYL PYRROLE DERIVATIVE | 2009 |
|
RU2470917C2 |
Authors
Dates
2018-03-07—Published
2013-04-25—Filed